Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VAC14 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | SNTA1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PSENEN | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | KCNQ1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | RYBP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | AP003419.11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | MYH10 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | IL10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PHKG2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |